Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Eosinophilic Pulmonary Diseases”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01463644
What this trial is testing

Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic Bronchitis

Who this might be right for
Chronic Obstructive Pulmonary DiseasesChronic Airways LimitationBronchitis
McMaster University 18
Not applicableNot Yet RecruitingNCT05762627
What this trial is testing

Severe Eosinophilic Asthma Phenotypes During Childhood Have Various Origins

Who this might be right for
Severe AsthmaAsthma in Children
Assistance Publique - Hôpitaux de Paris 360
Not applicableUnknownNCT05189613
What this trial is testing

Mepolizumab Effectiveness in Severe Eosinophilic Asthma and Bronchiectasis

Who this might be right for
Bronchial AsthmaBronchiectasis
Policlinico Universitario, Catania 100
Large-scale testing (Phase 3)Ended earlyNCT02594332
What this trial is testing

Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study

Who this might be right for
Asthma
Johannes Gutenberg University Mainz 29
Large-scale testing (Phase 3)Looking for participantsNCT06959095
What this trial is testing

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 981
Testing effectiveness (Phase 2)Study completedNCT01312961
What this trial is testing

Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma

Who this might be right for
Asthma
Sanofi 104
Not applicableActive Not RecruitingNCT03733535
What this trial is testing

Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI

Who this might be right for
Asthma; Eosinophilic
Dr. Grace Parraga 29
Not applicableUnknownNCT04924478
What this trial is testing

Evaluation of Volatile Organic Compounds in Mepolizumab Therapy

Who this might be right for
Asthma; Eosinophilic
University Hospital Southampton NHS Foundation Trust 60
Large-scale testing (Phase 3)Looking for participantsNCT07780656
What this trial is testing

Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 624
Not applicableActive Not RecruitingNCT05404763
What this trial is testing

Mepolizumab and Physical Activity in Severe Asthma

Who this might be right for
AsthmaAsthma; Eosinophilic
University Hospital, Lille 62
Large-scale testing (Phase 3)Looking for participantsNCT07190209
What this trial is testing

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Who this might be right for
Chronic Obstructive Pulmonary Disease
Sanofi 942
Testing effectiveness (Phase 2)Active Not RecruitingNCT03010436
What this trial is testing

Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study

Who this might be right for
Asthma
National Jewish Health 10
Early research (Phase 1)Not Yet RecruitingNCT06270576
What this trial is testing

Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma

Who this might be right for
Asthma; EosinophilicAsthma
National Jewish Health 60
Large-scale testing (Phase 3)Looking for participantsNCT07780669
What this trial is testing

Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 624
Not applicableStudy completedNCT07788092
What this trial is testing

Dupilumab in Type 2-Inflamed COPD Across the Full Spectrum of Airflow Limitation: An Italian Multicentre Retrospective Cohort Study

Who this might be right for
COPD (Chronic Obstructive Pulmonary Disease)COPDEosinophilia
Azienda Ospedaliera di Perugia 40
Post-approval studies (Phase 4)Study completedNCT04276233
What this trial is testing

Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma

Who this might be right for
Asthma
GlaxoSmithKline 100
Not applicableStudy completedNCT03696914
What this trial is testing

Intense Airway Eosinophilia in Asthma

Who this might be right for
AsthmaEosinophilic Asthma
Laval University 918
Post-approval studies (Phase 4)Study completedNCT00292838
What this trial is testing

Relative Potency of Inhaled Corticosteroids

Who this might be right for
AsthmaChronic Obstructive Pulmonary Disease (COPD)
St. Joseph's Healthcare Hamilton 40
Large-scale testing (Phase 3)Ended earlyNCT03052725
What this trial is testing

Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma

Who this might be right for
Eosinophils, Asthma
Teva Branded Pharmaceutical Products R&D, Inc. 391
Not applicableUnknownNCT04084613
What this trial is testing

Mepolizumab: Real World Evidence Study for the Treatment of Severe Eosinophilic Asthma in Greece

Who this might be right for
Severe Eosinophilic Asthma
Attikon Hospital 150
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation